T G Burke - JoVE Visualize

Showing results (31-40 of 40) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 40 results.

Pharmacotherapy|July 1, 1995

Thrombolytic-associated cholesterol emboli syndrome: case report and literature reviewD R Geraets, J D Hoehns, T G Burke, et al.

Biophysical Chemistry|April 1, 1990

Transverse location of anthracyclines in lipid bilayers. Paramagnetic quenching studiesP P Constantinides, Y Y Wang, T G Burke, et al.

Nucleic Acids Research|November 11, 1995

Molecular structure of the halogenated anti-cancer drug iododoxorubicin complexed with d(TGTACA) and d(CGATCG)I Berger, L Su, J R Spitzner, et al.

Molecular Pharmacology|May 1, 1987

Function of the anthracycline amino group in cellular transport and cytotoxicityT G Burke, M J Morin, A C Sartorelli, et al.

Cancer Research|October 16, 1999

Potent topoisomerase I inhibition by novel silatecans eliminates glioma proliferation in vitro and in vivoI F Pollack, M Erff, D Bom, et al.

Cancer Research|April 1, 1993

In vitro cytotoxicity, cellular pharmacology, and DNA lesions induced by annamycin, an anthracycline derivative with high affinity for lipid membranesY H Ling, W Priebe, L Y Yang, et al.

Chemistry and Physics of Lipids|October 1, 1988

Differential scanning calorimetric study of the thermotropic phase behavior of a polymerizable, tubule-forming lipidT G Burke, A S Rudolph, R R Price, et al.

Journal of Controlled Release : Official Journal of the Controlled Release Society|August 8, 2001

The highly lipophilic DNA topoisomerase I inhibitor DB-67 displays elevated lactone levels in human blood and potent anticancer activityD Bom, D P Curran, J Zhang, et al.

Journal of Medicinal Chemistry|October 29, 2000

The novel silatecan 7-tert-butyldimethylsilyl-10-hydroxycamptothecin displays high lipophilicity, improved human blood stability, and potent anticancer activityD Bom, D P Curran, S Kruszewski, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998

Phase I and pharmacokinetic study of GI147211, a water-soluble camptothecin analogue, administered for five consecutive days every three weeksS G Eckhardt, S D Baker, J R Eckardt, et al.

Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 40 results.

Pharmacotherapy|July 1, 1995

Thrombolytic-associated cholesterol emboli syndrome: case report and literature reviewD R Geraets, J D Hoehns, T G Burke, et al.

Biophysical Chemistry|April 1, 1990

Transverse location of anthracyclines in lipid bilayers. Paramagnetic quenching studiesP P Constantinides, Y Y Wang, T G Burke, et al.

Nucleic Acids Research|November 11, 1995

Molecular structure of the halogenated anti-cancer drug iododoxorubicin complexed with d(TGTACA) and d(CGATCG)I Berger, L Su, J R Spitzner, et al.

Molecular Pharmacology|May 1, 1987

Function of the anthracycline amino group in cellular transport and cytotoxicityT G Burke, M J Morin, A C Sartorelli, et al.

Cancer Research|October 16, 1999

Potent topoisomerase I inhibition by novel silatecans eliminates glioma proliferation in vitro and in vivoI F Pollack, M Erff, D Bom, et al.

Cancer Research|April 1, 1993

In vitro cytotoxicity, cellular pharmacology, and DNA lesions induced by annamycin, an anthracycline derivative with high affinity for lipid membranesY H Ling, W Priebe, L Y Yang, et al.

Chemistry and Physics of Lipids|October 1, 1988

Differential scanning calorimetric study of the thermotropic phase behavior of a polymerizable, tubule-forming lipidT G Burke, A S Rudolph, R R Price, et al.

Journal of Controlled Release : Official Journal of the Controlled Release Society|August 8, 2001

The highly lipophilic DNA topoisomerase I inhibitor DB-67 displays elevated lactone levels in human blood and potent anticancer activityD Bom, D P Curran, J Zhang, et al.

Journal of Medicinal Chemistry|October 29, 2000

The novel silatecan 7-tert-butyldimethylsilyl-10-hydroxycamptothecin displays high lipophilicity, improved human blood stability, and potent anticancer activityD Bom, D P Curran, S Kruszewski, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998

Phase I and pharmacokinetic study of GI147211, a water-soluble camptothecin analogue, administered for five consecutive days every three weeksS G Eckhardt, S D Baker, J R Eckardt, et al.

Pageof 4